Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
সব দামের পরিবর্তন →ইঙ্গিত ও ব্যবহার
Neomega এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
For hypertriglyceridaemia, it may be taken as a single dose of 4 capsules (4 gm), or as 2 capsules (2 gm) twice daily. For patients with a previous myocardial infarction, the usual dose is 1 capsule (1 gm) daily, taken with food. Patients should be placed on an appropriate lipid-lowering diet before starting Omega-3 Acid Ethyl Esters and should continue this diet throughout treatment. For joint inflammation associated with mild arthritis, the dose is 2.7 gm daily. For mood disorders, impulse control problems, and age-related macular degeneration, the dose is 1 capsule (1 gm) per day, or as directed by the registered physician.
পার্শ্বপ্রতিক্রিয়া
Immune system disorders: Rare, hypersensitivity. Metabolism and nutrition disorders: Uncommon, hyperglycaemia and gout. Nervous system disorders: Uncommon, dizziness, dysgeusia and headache. Vascular disorders: Uncommon, hypotension. Respiratory, thoracic and mediastinal disorders: Uncommon, epistaxis. Gastrointestinal disorders: Common, gastrointestinal complaints such as abdominal distension, abdominal pain, constipation, diarrhoea, dyspepsia, flatulence, eructation, gastro-oesophageal reflux disease, nausea or vomiting; Uncommon, gastrointestinal haemorrhage. Hepatobiliary disorders: Rare, liver disorders including raised transaminases, alanine aminotransferase and aspartate aminotransferase. Skin and subcutaneous tissue disorders: Uncommon, rash; Rare, urticaria.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
Because of the moderate increase in bleeding time seen with the high dosage (4 capsules), patients receiving anticoagulant therapy must be monitored, and the anticoagulant dosage adjusted if necessary. Using this medication does not remove the need for the usual monitoring in these patients. Extra allowance should be made for the increased bleeding time in patients at high risk of haemorrhage, such as after severe trauma or surgery. Because there is no efficacy and safety data in children, use of this medication in children is not recommended. During treatment with Neomega-acid ethyl esters, thromboxane A2 production falls, while no significant effect has been observed on other coagulation factors. Some studies with omega-3 acids showed a prolongation of bleeding time, but in these studies the bleeding time did not exceed normal limits and did not cause clinically significant bleeding episodes. Some patients showed a small but significant rise in ASAT and ALAT, still within normal values, though there is no evidence that patients with hepatic impairment face increased risk. ALAT and ASAT levels should be monitored in patients showing any signs of liver damage, particularly with the high dosage (4 capsules). Neomega-acid ethyl esters is not indicated in exogenous hypertriglyceridaemia (type 1 hyperchylomicronaemia). Experience in secondary endogenous hypertriglyceridaemia, especially in uncontrolled diabetes, is limited, and there is no experience with its use for hypertriglyceridaemia combined with fibrates.
নিষেধাজ্ঞা
It is contraindicated in anyone known to be hypersensitive to any of its ingredients.